Table 3.
Findings | Associations |
---|---|
Laboratory testing (refer to local reference values) | |
17-hydroxyprogesterone level (collected at 8:00 AM) | High: nonclassic CAH |
Anti-Müllerian hormone | High: Functional hypothalamic amenorrhea, PCOS |
Low: Primary ovarian insufficiency | |
Complete blood count and metabolic panel | Abnormal: chronic disease (e.g., elevated liver enzymes in functional hypothalamic amenorrhea) |
Estradiol | Low: Poor endogenous estrogen production (suggestive of poor current ovarian function) |
Follicle stimulating hormone and luteinizing hormone | High: primary ovarian insufficiency; Turner syndrome, FSH receptor mutation |
Low: functional hypothalamic amenorrhea | |
Normal: PCOS; intrauterine adhesions; multiple others | |
Free and total T, DHEA-S | High: hyperandrogenism, PCOS, ovarian or adrenal tumor, CAH, Cushing syndrome |
T/DHT ratio (normal <30:1) | High: 5-α-reductase deficiency |
At puberty, serum LH, and T | High: androgen insensitivity syndrome |
Karyotype | Abnormal: turner syndrome, rare chromosomal disorders |
Prolactin | High: pituitary adenoma, medications, hypothyroidism, other neoplasm |
Thyroid-stimulating hormone | High: hypothyroidism |
Low: hyperthyroidism | |
Radiographic testing | |
Dual-energy X-ray absorptiometry | Evaluation of fracture risk |
MRI of the adrenal glands | Androgen-secreting adrenal tumor |
MRI of the brain (including sella) | Tumor (e.g., microadenoma) |
Pelvic organ ultrasonography or MRI | Morphology of pelvic organs, polycystic ovarian morphology, androgen-secreting ovarian tumor |
CAH, congenital adrenal hyperplasia; PCOS, polycystic ovary syndrome; FSH, follicle stimulating hormone; DHEA-S, dehydroepiandrosterone sulfate; DHT, dihysrotestosterone; LH, luteinizing hormone; MRI, magnetic resonance imaging; T, testosterone.
Modified from Klein et al., Am Fam Physician 2019;100:39-48, with permission of American Academy of Family Physicians. [5]